Join our live panel discussion, featuring leading pharmaceutical industry executives from AbbVie, AstraZeneca and Bayer reviewing commercial execution in the last 24 months, including learnings and challenges, trends within the organisation and in the wider industry. As COVID-19 continues to evolve, they will examine the commercial engagement strategy of the future. The panel will deliberate on new processes, skills and capabilities to enhance commercial execution.
Speakers
CHRIS STEMPLE
ABBVIE
Vice President and General Manager, ANZ
VINOD NARAYANAN
ASTRAZENECA
Country President, Singapore
SIAN DAVIS
ASTRAZENECA
Head of Field Medical, CVRM
ASHRAF AL-OUF
BAYER
General Manager - Pharmaceuticals ANZ